IP Library Granted Patent US 8,900,623
Granted Patent B2
US 8,900,623 · App. 13/387,362 · Granted Dec 2, 2014

Sticky soft gel for treating poultry

Inventor: Eng-Hong Lee (Guelph, CA)
Assignee: Vetech Laboratories Inc.
A23K1/1643A23K1/002A23K1/1826A23L1/05A61K9/0095A61K9/06A61K9/7015A61K39/0275A61K39/12A61K39/17A61K47/36C12N2760/18134
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,900,623
App. No.
13/387,362
Granted
Dec 2, 2014
Kind
B2
Abstract

The present invention is directed to a composition, kit and method for delivering a soft flowable gel to a flock of poultry in barns, but can also be used in hatcheries or free range farms, for treating poultry with a therapeutic agent. The soft flowable gel comprises water, a gelling agent, a therapeutic agent and between about 0.05% and 0.15% xanthan gum.

Claims (44)

1. A dry powder mixture comprising:

a) 2-5% w/w carboxymethyl cellulose;

b) 2-6% w/w xanthan gum;

c) 20-30% w/w maltodextrin or carrageenan; and

d) 60-70% w/w maltodextrin or carrageenan;

wherein when maltodextrin is present in an amount of 20-30% w/w, then carrageenan is present in an amount of 60-70% w/w, and when carrageenan is present in an amount of 20-30% w/w, then maltodextrin is present in an amount of 60-70% w/w; and

wherein the dry powder mixture forms a sticky soft flowable gel in suspension in water.

2. The dry powder mixture of claim 1 wherein the sticky gum is xanthan gum provided in an amount to constitute about 0.05-0.15% w/v of the soft flowable gel.

3. The dry powder mixture of claim 1 wherein the carrageenan and the maltodextrin in combination are provided in an amount to constitute about 0.5-2.5% w/v of the sticky soft flowable gel.

4. The dry powder mixture of claim 1 wherein one of the carrageenan and the maltodextrin is provided in an amount to constitute about 1.5-1.75% w/v of the sticky soft flowable gel, and the other of the carrageenan and the maltodextrin is provided in an amount to constitute about 0.5-0.75% w/v of the sticky soft flowable gel.

5. A sticky soft flowable gel composition for use in treating a flock of poultry comprising:

i) a dry powder mixture comprising:

a) 2-5% w/w carboxymethyl cellulose;

b) 2-6% w/w xanthan gum;

c) 20-30% w/w maltodextrin or carrageenan; and

d) 60-70% w/w maltodextrin or carrageenan, wherein when maltodextrin is present in an amount of 20-30% w/w, then carrageenan is present in an amount of 60-70% w/w, and when carrageenan is present in an amount of 20-30% w/w, then maltodextrin is present in an amount of 60-70% w/w;

ii) water; and

iii) a therapeutic agent.

6. The sticky soft flowable gel composition of claim 5 wherein the carrageenan and the maltodextrin in combination are in an amount of about 0.5-2.5% w/v of the sticky soft flowable gel.

7. The sticky soft flowable gel composition of claim 5 wherein one of the carrageenan and the maltodextrin is in an amount of about 1.5-1.75% w/v of the sticky soft flowable gel, and the other of the carrageenan and the maltodextrin is in an amount of about 0.5-0.75% w/v of the sticky soft flowable gel.

8. The sticky soft flowable gel composition of claim 5 wherein the therapeutic agent is a therapeutically effective amount of at least one therapeutic agent selected from the group consisting of

a) a live organism selected from the group consisting of Hemorrhagic Enteritis Virus (HE), Infectious Bursal Disease Virus (IBD), Newcastle Disease Virus (ND), Salmonella , Infectious Bronchitis, Infectious Laryngotracheitis, Mycoplasma sp., a Pneumovirus, Coccidiosis, and a competitive exclusion product, wherein said competitive exclusion product is a probiotic,

b) vitamins,

c) minerals, and

d) electrolytes.

9. A kit for treating a flock of poultry comprising a dry powder mixture in a first container, wherein the dry powder mixture is suspended in water thereby forming a sticky soft flowable gel, and a therapeutic agent in the first container or in a second container, wherein the therapeutic agent is for dissolution or suspension in the sticky soft flowable gel, the dry powder mixture comprising:

a) 2-5% w/w carboxymethyl cellulose;

b) 2-6% w/w xanthan gum;

c) 20-30% w/w maltodextrin or carrageenan; and

d) 60-70% w/w maltodextrin or carrageenan;

wherein when maltodextrin is present in an amount of 20-30% w/w, then carrageenan is present in an amount of 60-70% w/w, and when carrageenan is present in an amount of 20-30% w/w, then maltodextrin is present in an amount of 60-70% w/w.

10. The kit of claim 9 wherein the sticky gum is xanthan gum provided in an amount to constitute about 0.05-0.15% w/v of the soft flowable gel.

11. The kit of claim 9 wherein the carrageenan and the maltodextrin in combination are provided in an amount to constitute about 0.5-2.5% w/v of the sticky soft flowable gel.

12. The kit of claim 9 wherein one of the carrageenan and the maltodextrin is provided in an amount to constitute about 1.5-1.75% w/v of the sticky soft flowable gel, and the other of the carrageenan and the maltodextrin is provided in an amount to constitute about 0.5-0.75% w/v of the sticky soft flowable gel.

13. The kit of claim 9 wherein the therapeutic agent is at least one therapeutic agent selected from

A) in the second container, the therapeutic agent which is

i) a therapeutically effective amount of at least one live organism selected from the group consisting of Hemorrhagic Enteritis Virus (HE), Infectious Bursal Disease Virus (IBD), Newcastle Disease Virus (ND), Salmonella , Infectious Bronchitis, Infectious Laryngotracheitis, Mycoplasma sp., a Pneumovirus, Coccidiosis, and a competitive exclusion product, wherein said competitive exclusion product is a probiotic; and

B) in the first container or in the second container, the therapeutic agent which is a therapeutically effective amount of at least one therapeutic agent selected from the group consisting of

i) vitamins,

ii) minerals, and

iii) electrolytes.

14. The kit of claim 13 wherein the therapeutic agent is Infectious Bursal Disease Virus.

15. The sticky soft flowable gel composition of claim 8 , wherein the probiotic is a lactobacillus or bacillus species.

16. The kit of claim 13 , wherein the probiotic is a lactobacillus or bacillus species.

Assignments (2)
CHANGE OF NAME Recorded Apr 15, 2016
From: VETECH LABORATORIES INC.
To: CEVA ANIMAL HEALTH INC.
Reel/Frame 038441/0021 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 26, 2012
From: LEE, ENG-HONG
To: VETECH LABORATORIES INC.
Reel/Frame 028109/0322 →
Priority Claims (1)
CA 2674143 · Jul 28, 2009 · national
Continuity (1)
Related Publication 20120121644A1 · May 17, 2012